VRDN
Viridian Therapeutics Inc
NASDAQ: VRDN · HEALTHCARE · BIOTECHNOLOGY
$13.30
-2.28% today
Updated 2026-04-29
Market cap
$1.37B
P/E ratio
—
P/S ratio
19.35x
EPS (TTM)
$-3.32
Dividend yield
—
52W range
$12 – $34
Volume
2.3M
Viridian Therapeutics Inc (VRDN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+18.1%
Last 4 quarters
Revenue YoY growth
+83.3%
Most recent quarter
EPS YoY growth
-33.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+3.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+22.0%
2025-11-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-05 | $-1.08 | -13.0% | $30.39 | $28.34 | -6.7% |
| 2025-11-05 | $-0.34 | +64.3% | $22.55 | $27.50 | +22.0% |
| 2025-08-06 | $-1.00 | +0.0% | $17.44 | $16.53 | -5.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.96 | $-1.08 | -13.0% | $132000.00 | +83.3% |
| 2025-09-30 | $-0.95 | $-0.34 | +64.3% | $70.57M | +81958.1% |
| 2025-06-30 | $-1.00 | $-1.00 | +0.0% | $75000.00 | +4.2% |
| 2025-03-31 | $-1.10 | $-0.87 | +21.0% | $72000.00 | +0.0% |
| 2024-12-31 | $-1.04 | $-0.81 | +22.4% | $72000.00 | +0.0% |
| 2024-09-30 | $-1.06 | $-1.15 | -8.9% | $86000.00 | +19.4% |
| 2024-06-30 | $-0.89 | $-1.02 | -14.6% | $72000.00 | +0.0% |
| 2024-03-31 | $-1.10 | $-0.79 | +28.2% | $72000.00 | -26.5% |
| 2023-12-31 | $-1.00 | $-1.35 | -35.0% | $72000.00 | — |
| 2023-09-30 | $-1.27 | $-1.09 | +14.2% | $72000.00 | — |
| 2023-06-30 | $-1.29 | $-1.27 | +1.6% | $72000.00 | — |
| 2023-03-31 | $-1.02 | $-1.61 | -57.8% | $98000.00 | — |
Frequently asked questions
Has Viridian Therapeutics Inc beaten earnings estimates?
Viridian Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +18.1% over the last 4 quarters.
How does VRDN stock react to earnings?
VRDN stock has moved an average of +3.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Viridian Therapeutics Inc's revenue growth rate?
Viridian Therapeutics Inc reported year-over-year revenue growth of +83.3% in its most recent quarter, with EPS growing -33.3% year-over-year.